NO942267L - Behandling av periodontalsykdom med alendronat - Google Patents
Behandling av periodontalsykdom med alendronatInfo
- Publication number
- NO942267L NO942267L NO942267A NO942267A NO942267L NO 942267 L NO942267 L NO 942267L NO 942267 A NO942267 A NO 942267A NO 942267 A NO942267 A NO 942267A NO 942267 L NO942267 L NO 942267L
- Authority
- NO
- Norway
- Prior art keywords
- periodontal disease
- alendronate
- treatment
- tridydrate
- peridontitis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/808,701 US5270365A (en) | 1991-12-17 | 1991-12-17 | Prevention and treatment of periodontal disease with alendronate |
PCT/US1992/010534 WO1993011774A1 (en) | 1991-12-17 | 1992-12-08 | Treatment of periodontal disease with alendronate |
Publications (3)
Publication Number | Publication Date |
---|---|
NO942267D0 NO942267D0 (no) | 1994-06-16 |
NO942267L true NO942267L (no) | 1994-06-16 |
NO306197B1 NO306197B1 (no) | 1999-10-04 |
Family
ID=25199466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO942267A NO306197B1 (no) | 1991-12-17 | 1994-06-16 | Anvendelse av 4-amino-1-hydroksybutyliden-1, 1-bis-fosfonsyre |
Country Status (22)
Country | Link |
---|---|
US (1) | US5270365A (no) |
EP (1) | EP0617624B1 (no) |
JP (1) | JP2825654B2 (no) |
KR (1) | KR100258667B1 (no) |
AT (1) | ATE150646T1 (no) |
AU (1) | AU675417B2 (no) |
CA (1) | CA2122498A1 (no) |
CY (1) | CY2054B1 (no) |
CZ (1) | CZ282902B6 (no) |
DE (1) | DE69218624T2 (no) |
DK (1) | DK0617624T3 (no) |
ES (1) | ES2100519T3 (no) |
GR (1) | GR3022951T3 (no) |
HK (1) | HK1000114A1 (no) |
HU (1) | HU221807B1 (no) |
IL (1) | IL104109A (no) |
LV (1) | LV12084B (no) |
NO (1) | NO306197B1 (no) |
NZ (1) | NZ246274A (no) |
SK (1) | SK280628B6 (no) |
WO (1) | WO1993011774A1 (no) |
ZA (1) | ZA929712B (no) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW237386B (no) * | 1992-04-15 | 1995-01-01 | Ciba Geigy | |
US5403829A (en) * | 1993-03-24 | 1995-04-04 | Leiras Oy | Use of bisphosphonates in endo-osteal bone surgery |
FR2703590B1 (fr) * | 1993-04-05 | 1995-06-30 | Sanofi Elf | Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse . |
US5854227A (en) * | 1994-03-04 | 1998-12-29 | Hartmann; John F. | Therapeutic derivatives of diphosphonates |
WO1995028145A1 (en) * | 1994-04-18 | 1995-10-26 | The Procter & Gamble Company | Iontophoretic delivery of bisphosphonates to the alveolar bone |
US5646134A (en) * | 1994-04-21 | 1997-07-08 | Merck & Co., Inc. | Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices |
US5462932A (en) * | 1994-05-17 | 1995-10-31 | Merck & Co., Inc. | Oral liquid alendronate formulations |
US5780455A (en) * | 1994-08-24 | 1998-07-14 | Merck & Co., Inc. | Intravenous alendronate formulations |
US6008206A (en) * | 1994-09-21 | 1999-12-28 | Merck & Co., Inc. | Sodium alendronate preparation for local administration |
JP3411690B2 (ja) * | 1994-09-21 | 2003-06-03 | 帝人株式会社 | 局所投与用アレンドロン酸ナトリウム製剤 |
CN1181012A (zh) * | 1995-02-17 | 1998-05-06 | 麦克公司 | 减小非椎骨骨折危险的方法 |
EP0824341A4 (en) * | 1995-05-12 | 1999-07-07 | Merck & Co Inc | PREVENTING TOOTH LOSS THROUGH ADMINISTRATION OF ALENDRONATE OR ITS SALTS |
US6117856A (en) * | 1996-02-14 | 2000-09-12 | Binderman; Itzhak | Topical bisphosphonates for prevention of bone resorption |
CA2245793A1 (en) * | 1996-02-14 | 1997-08-21 | Itzhak Binderman | Topical bisphosphonates for prevention of bone resorption |
AU712710B2 (en) * | 1996-05-17 | 1999-11-11 | Merck Sharp & Dohme Corp. | Effervescent bisphosphonate formulation |
US5853759A (en) * | 1996-05-17 | 1998-12-29 | Merck & Co.. Inc. | Effervescent alendronate formulation |
EP1378234A1 (en) * | 1996-05-17 | 2004-01-07 | MERCK & CO. INC. | Effervescent bisphosphonate formulation |
TR199900730T2 (xx) * | 1996-10-04 | 1999-07-21 | Merck & Co., Inc | S�v� alendronat form�lasyonlar� |
US5773429A (en) * | 1996-12-11 | 1998-06-30 | Fuisz Technologies Ltd. | Drug combination for treating calcium loss |
US20010031244A1 (en) * | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
DE122007000063I1 (de) * | 1997-07-22 | 2007-12-20 | Merck & Co Inc | Alendronate zur Behandlung von Osteoporose |
US6432932B1 (en) | 1997-07-22 | 2002-08-13 | Merck & Co., Inc. | Method for inhibiting bone resorption |
US5994329A (en) * | 1997-07-22 | 1999-11-30 | Merck & Co., Inc. | Method for inhibiting bone resorption |
FR2784031B1 (fr) * | 1998-10-02 | 2002-02-01 | Sanofi Elf | Utilisation de derives de l'acide bisphosphonique pour la preparation d'un medicament destine au traitement des boiteries |
US6331533B1 (en) * | 1998-11-16 | 2001-12-18 | Merck & Co., Inc. | Method for inhibiting dental resorptive lesions |
TR200101841T2 (tr) * | 1998-12-23 | 2001-12-21 | Jomaa Pharmaka Gmbh | Enfeksiyonlardan korunmak ve enfeksiyon tedavisi için bifosfonatların kullanılmaları |
US6315566B1 (en) | 1999-05-18 | 2001-11-13 | 3M Innovative Properties Company | Dental materials |
US6143919A (en) * | 1999-05-18 | 2000-11-07 | 3M Innovative Properties Company | Polymerizable acidic compounds and methods of preparation |
PL196485B1 (pl) * | 2000-05-11 | 2008-01-31 | Inst Farmaceutyczny | Stała doustna kompozycja farmaceutyczna zawierająca aminową pochodną kwasu bisfosfonowego i sposób jej wytwarzania |
GB0029111D0 (en) * | 2000-11-29 | 2001-01-10 | Novartis Ag | Organic compounds |
US20030216358A1 (en) * | 2001-07-05 | 2003-11-20 | Muchmore Douglas Boyer | Method for enhancing bone mineral density gain |
US20040053968A1 (en) * | 2001-12-28 | 2004-03-18 | Hartman George D. | Methods and compositions for treating peridontal disease |
US20070094865A1 (en) * | 2002-01-10 | 2007-05-03 | Ji-Guang Zhang | Packaged thin film batteries and methods of packaging thin film batteries |
US7960054B2 (en) * | 2002-01-10 | 2011-06-14 | Excellatron Solid State Llc | Packaged thin film batteries |
US7488496B2 (en) * | 2002-03-06 | 2009-02-10 | Christer Rosen | Effervescent compositions comprising bisphosphonates and methods related thereto |
AU2003226148A1 (en) * | 2002-04-05 | 2003-10-27 | Merck & Co., Inc. | Method for inhibiting bone resorption with an alendronate and vitamin d formulation |
FR2838339B1 (fr) * | 2002-04-12 | 2005-06-24 | Univ Angers | Derives poly-phosphonates pour compositions dentifrices |
US20040137058A1 (en) * | 2002-07-09 | 2004-07-15 | Katdare Ashok V. | Effervescent bisphosphonate formulation |
US20050142185A1 (en) * | 2003-12-29 | 2005-06-30 | Beleno Alfredo B. | Softgel formulations of bisphosphonates bone resorption inhibitors |
US20060034921A1 (en) * | 2004-01-05 | 2006-02-16 | Katdare Ashok V | Effervescent bisphosphonate formulation |
US20050181043A1 (en) * | 2004-02-12 | 2005-08-18 | Indranil Nandi | Alendronate salt tablet compositions |
US20080070087A1 (en) * | 2004-02-20 | 2008-03-20 | Excellatron Solid State, Llc | Non-volatile cathodes for lithium oxygen batteries and method of producing same |
US20050261250A1 (en) * | 2004-05-19 | 2005-11-24 | Merck & Co., Inc., | Compositions and methods for inhibiting bone resorption |
KR100564628B1 (ko) * | 2004-06-16 | 2006-03-28 | 삼성전자주식회사 | 스플릿 게이트형 플래쉬 메모리 소자 및 그 제조방법 |
US20060134190A1 (en) * | 2004-12-16 | 2006-06-22 | Banner Pharmacaps Inc. | Formulations of bisphosphonate drugs with improved bioavailability |
US7540886B2 (en) * | 2005-10-11 | 2009-06-02 | Excellatron Solid State, Llc | Method of manufacturing lithium battery |
US20070087052A1 (en) * | 2005-10-19 | 2007-04-19 | Katdare Ashok V | Effervescent bisphosphonate formulation |
JP2009529768A (ja) | 2006-03-10 | 2009-08-20 | エクセラトロン ソリッド ステート,エルエルシー | 空気電池及びその製造方法 |
US20090118238A1 (en) * | 2007-09-17 | 2009-05-07 | Protia, Llc | Deuterium-enriched alendronate |
WO2011017253A1 (en) | 2009-08-03 | 2011-02-10 | Chimerix, Inc. | Composition and methods of treating viral infections and viral induced tumors |
US8882740B2 (en) * | 2009-12-23 | 2014-11-11 | Stryker Trauma Gmbh | Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone |
RU2449761C1 (ru) * | 2011-03-09 | 2012-05-10 | Светлана Минифаритовна Алетдинова | Способ лечения хронических апикальных периодонтитов |
GB201200868D0 (en) | 2012-01-19 | 2012-02-29 | Depuy Int Ltd | Bone filler composition |
US9579360B2 (en) * | 2012-06-20 | 2017-02-28 | The Trustees Of The University Of Pennsylvania | Methods of treating or preventing periodontitis and diseases associated with periodontitis |
RU2713257C1 (ru) * | 2019-05-06 | 2020-02-04 | Жанна Владимировна Вечеркина | Способ лечения хронического апикального периодонтита |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3429963A (en) * | 1964-06-09 | 1969-02-25 | Colgate Palmolive Co | Dental preparation containing polymeric polyelectrolyte |
US4134969A (en) * | 1974-02-04 | 1979-01-16 | Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa) | Method of treatment of calcium disorders using aminoalkane-diphosphonic acids |
DE2405254C2 (de) * | 1974-02-04 | 1982-05-27 | Henkel KGaA, 4000 Düsseldorf | Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper |
US4042679A (en) * | 1975-11-07 | 1977-08-16 | Colgate-Palmolive Company | Antibacterial oral composition |
US4138477A (en) * | 1976-05-28 | 1979-02-06 | Colgate Palmolive Company | Composition to control mouth odor |
US4440779A (en) * | 1981-06-30 | 1984-04-03 | Merck & Co., Inc. | Tricyclic derivatives of substituted pyrrole acids as analgesic and anti-inflammatory agents |
IT1201087B (it) * | 1982-04-15 | 1989-01-27 | Gentili Ist Spa | Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche |
US4446052A (en) * | 1982-05-17 | 1984-05-01 | The Procter & Gamble Company | Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate |
US4639338A (en) * | 1984-08-06 | 1987-01-27 | Ciba-Geigy Corporation | Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate |
US4647453A (en) * | 1984-10-18 | 1987-03-03 | Peritain, Ltd. | Treatment for tissue degenerative inflammatory disease |
US4677132A (en) * | 1986-03-12 | 1987-06-30 | American Home Products Corporation | Inhibition of bone resorption by etodolac |
IL84493A (en) * | 1986-11-21 | 1993-01-14 | Ciba Geigy Ag | Aromatically substituted azacycloalkylalk - anediphosphonic acids, their preparation and pharmaceutical compositions containing them |
EP0274346B1 (de) * | 1986-11-21 | 1991-03-06 | Ciba-Geigy Ag | Neue Substituiertaminomethandiphosphonsäuren |
US4973576A (en) * | 1987-03-10 | 1990-11-27 | Yamanouchi Pharmaceutical Co., Ltd. | Bisphophonic acid derivatives and pharmaceutical compositions containing the same |
US4816437A (en) * | 1987-06-01 | 1989-03-28 | Trustees Of Boston University | Methods for inducing general and localized bone apposition in-vivo |
EP0317505A1 (de) * | 1987-11-13 | 1989-05-24 | Ciba-Geigy Ag | Neue Azacycloalkylalkandiphosphonsäuren |
GB8726714D0 (en) * | 1987-11-14 | 1987-12-16 | Beecham Group Plc | Compounds |
EP0320455B1 (de) * | 1987-12-11 | 1993-06-09 | Ciba-Geigy Ag | Araliphatylaminoalkandiphosphonsäuren |
US4877603A (en) * | 1987-12-18 | 1989-10-31 | The Procter & Gamble Company | Oral compositions |
DE3822650A1 (de) * | 1988-07-05 | 1990-02-01 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
US4990503A (en) * | 1988-08-12 | 1991-02-05 | Yamanouchi Pharmaceutical Co., Ltd. | Heterocyclic bisphosphonic acid derivatives |
CA2035179C (en) * | 1990-01-31 | 2001-08-14 | Gerald S. Brenner | Pharmaceutical compositions containing insoluble salts of bisphosphonic acids |
GB9008433D0 (en) * | 1990-04-12 | 1990-06-13 | Beecham Group Plc | Novel compositions |
US5019651A (en) * | 1990-06-20 | 1991-05-28 | Merck & Co., Inc. | Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof |
-
1991
- 1991-12-17 US US07/808,701 patent/US5270365A/en not_active Expired - Fee Related
-
1992
- 1992-12-08 CZ CZ941487A patent/CZ282902B6/cs not_active IP Right Cessation
- 1992-12-08 CA CA002122498A patent/CA2122498A1/en not_active Abandoned
- 1992-12-08 KR KR1019940702159A patent/KR100258667B1/ko not_active IP Right Cessation
- 1992-12-08 HU HU9401378A patent/HU221807B1/hu not_active IP Right Cessation
- 1992-12-08 SK SK727-94A patent/SK280628B6/sk unknown
- 1992-12-08 DE DE69218624T patent/DE69218624T2/de not_active Expired - Fee Related
- 1992-12-08 EP EP93900917A patent/EP0617624B1/en not_active Expired - Lifetime
- 1992-12-08 WO PCT/US1992/010534 patent/WO1993011774A1/en active IP Right Grant
- 1992-12-08 AT AT93900917T patent/ATE150646T1/de not_active IP Right Cessation
- 1992-12-08 DK DK93900917.1T patent/DK0617624T3/da active
- 1992-12-08 JP JP5510996A patent/JP2825654B2/ja not_active Expired - Fee Related
- 1992-12-08 NZ NZ246274A patent/NZ246274A/en unknown
- 1992-12-08 ES ES93900917T patent/ES2100519T3/es not_active Expired - Lifetime
- 1992-12-08 AU AU32420/93A patent/AU675417B2/en not_active Ceased
- 1992-12-15 ZA ZA929712A patent/ZA929712B/xx unknown
- 1992-12-16 IL IL10410992A patent/IL104109A/xx not_active IP Right Cessation
-
1994
- 1994-06-16 NO NO942267A patent/NO306197B1/no unknown
-
1997
- 1997-03-27 GR GR970400482T patent/GR3022951T3/el unknown
- 1997-08-04 HK HK97101629D patent/HK1000114A1/xx not_active IP Right Cessation
-
1998
- 1998-03-06 LV LVP-98-43A patent/LV12084B/en unknown
- 1998-04-30 CY CY9802054A patent/CY2054B1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
HUT68788A (en) | 1995-07-28 |
AU3242093A (en) | 1993-07-19 |
NO942267D0 (no) | 1994-06-16 |
IL104109A0 (en) | 1993-05-13 |
LV12084B (en) | 1998-11-20 |
CY2054B1 (en) | 1998-04-30 |
JPH07502506A (ja) | 1995-03-16 |
CZ282902B6 (cs) | 1997-11-12 |
JP2825654B2 (ja) | 1998-11-18 |
LV12084A (lv) | 1998-07-20 |
NO306197B1 (no) | 1999-10-04 |
ATE150646T1 (de) | 1997-04-15 |
EP0617624B1 (en) | 1997-03-26 |
ES2100519T3 (es) | 1997-06-16 |
HU9401378D0 (en) | 1994-08-29 |
HU221807B1 (hu) | 2003-01-28 |
WO1993011774A1 (en) | 1993-06-24 |
SK72794A3 (en) | 1995-04-12 |
DK0617624T3 (da) | 1997-04-21 |
ZA929712B (en) | 1993-06-14 |
SK280628B6 (sk) | 2000-05-16 |
EP0617624A1 (en) | 1994-10-05 |
CA2122498A1 (en) | 1993-06-24 |
KR940703676A (ko) | 1994-12-12 |
HK1000114A1 (en) | 1997-12-05 |
US5270365A (en) | 1993-12-14 |
DE69218624D1 (de) | 1997-04-30 |
CZ148794A3 (en) | 1995-03-15 |
IL104109A (en) | 1997-02-18 |
GR3022951T3 (en) | 1997-06-30 |
NZ246274A (en) | 1997-02-24 |
AU675417B2 (en) | 1997-02-06 |
DE69218624T2 (de) | 1997-08-07 |
KR100258667B1 (ko) | 2000-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO942267L (no) | Behandling av periodontalsykdom med alendronat | |
ES2169046T3 (es) | Analogo de prostaglandina para el tratamiento de la osteoporosis. | |
NO952890L (no) | Kombinasjonsbehandling for inhibisjon av bentap | |
CY1106482T1 (el) | Φαρμακευτικη παρεντepικη συνθεση πepιεχοντας ενα διφωσφονικο | |
RU93054537A (ru) | Производные гуанидиналкил-1,1-бисфосфоновой кислоты, способ их получения и их применение | |
DE3867736D1 (de) | Methylenphosphonalkylphosphinate, pharmazeutische zubereitungen und verfahren zur behandlung abnormalen kalzium- und phosphat-stoffwechsels. | |
DK0833643T3 (da) | Formuleringer af vandfrit mononatriumsalt af alendronat og deres anvendelse til behandling af knoglesygdomme | |
DE69031340D1 (de) | 3'-azido-2',3'-dideoxy-5-methylcytidin enthaltende antivirale zusammensetzungen | |
ES2136167T3 (es) | Composiciones de idebenona para tratar la enfermedad de alzheimer. | |
IL133172A0 (en) | Diphosphonic acid salts for the treatment of osteoporosis | |
EE9600191A (et) | Püridüülbisfosfonaatide kasutamine terapeutiliste toimeainetena | |
ATE135681T1 (de) | Diclofenac-cholinsalz, verfahren zur herstellung und pharmazeutische zusammensetzungen, die es enthalten | |
KR970705400A (ko) | 골 활성 포스포네이트 및 부갑상선 호르몬을 사용한 골다공증의 치료방법(methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone) | |
HUT48464A (en) | Process for producing pharmaceutical composition for treating hypertonia and cardiac failure | |
ATE169302T1 (de) | Phosphono suphonate verbindungen zur behandlung abnormalen kalzium- und phospat- metabolismuses | |
NO944517D0 (no) | Kvarternære nitrogen-inneholdende fosfonatforbindelser for behandling av abnormal kalsium- og fosfatmetabolisme | |
DK0612246T3 (da) | Farmaceutiske sammensætninger af galliumkomplekser med 3-hydroxy-4-pyroner | |
DE69007777D1 (de) | Derivate der p-Guanidinobenzoesäure zur Behandlung der zerebrovaskulären Kontraktion. |